RMD
$225.99-1.42 (-0.62%)
ResMed Inc.
Recent News
ResMed (RMD) Valuation Check After Recent Share Price Pullback And Growth Expectations
ResMed stock performance and recent context ResMed (RMD) has drawn attention after recent trading, with shares last closing at US$225.99. The stock shows a 0.6% decline over the past day and softer returns over the week, month, and past 3 months. See our latest analysis for ResMed. Recent trading reflects fading short term momentum, with a 30 day share price return of a 12.8% decline and a year to date share price return of a 7.7% decline, while 1 year total shareholder return is 3.8%. If...
After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)
ResMed (RMD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ResMed (RMD) Upgraded to Buy: Here's What You Should Know
ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Resmed Stock the Right Pick for Your Portfolio Now?
RMD expands mask and device sales while maintaining strong liquidity, but macro and competitive pressures loom.
After Plunging 8.7% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)
The heavy selling pressure might have exhausted for ResMed (RMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.